This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Equine Matrix Metalloproteinase-9 (MMP9)
Product Overview
BioVenic's Recombinant Equine Matrix Metalloproteinase-9 (MMP9) is a recombinant protein expressed from Yeast. Its predicted molecular weight is 69.0 kDa. The purity is>85% (SDS-PAGE).
Specifications
Target Information
Equine matrix metalloproteinase-9 (MMP9) is an enzyme that plays a critical role in the breakdown of extracellular matrix in horses. It is involved in physiological processes such as tissue remodeling, wound healing, and immune responses. In veterinary medicine, MMP9 is significant for diagnosing and monitoring inflammatory diseases and musculoskeletal disorders. It can also serve as a biomarker for exercise-induced damage or injury in performance horses.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Aliquot the reconstituted solution to minimise freeze-thaw cycles.